SCHEMBL7401162

SCHEMBL7401162

COc1ccc(C=Cc2nc3c([nH]2)c(=O)n(C)c(=O)n3C)cc1OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7401160 1.00 — —
SCHEMBL7306273 0.90 — —
SCHEMBL7732165 0.87 — —
SCHEMBL7397100 0.85 ADORA2B (0.62) —
SCHEMBL7397099 0.85 ADORA2B (0.62) —
SCHEMBL7722412 0.83 ADORA2A (0.64) —
SCHEMBL7722409 0.83 ADORA2A (0.64) —
SCHEMBL5142366 0.82 — —
SCHEMBL5142368 0.82 — —
SCHEMBL7310644 0.81 ADORA2A (0.62) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5861405-A A2-SELECTIVE ADENOSINE RECEPTOR ANTAGONIST AS ANTIDEPRESSANTS AND CNS STIMULANTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-01-19 — — US disclosed
WO-1994025462-A1 8-SUBSTITUTED 1,3,7-TRIALKYL-XANTHINE DERIVATIVES AS A2-SELECTIVE ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, REPRESENTED BY THE (US) 1994-11-10 — — WO disclosed
Send feedback